Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stacey Berg

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Pediatric Blood & Cancer|November 19, 2016
Using decision modeling to guide drug allocation during a shortageHeidi V Russell, M Brooke Bernhardt, Stacey Berg
Pediatric Blood & Cancer|June 19, 2008
Valacyclovir and acyclovir pharmacokinetics in immunocompromised childrenLisa Bomgaars, Patrick Thompson, Stacey Berg, et al.
Cancer Chemotherapy and Pharmacology|October 11, 2003
Plasma and cerebrospinal fluid pharmacokinetics of SU5416 after intravenous administration in nonhuman primatesJamie Renbarger, Alexander Aleksic, Leticia McGuffey, et al.
Pediatric Blood & Cancer|November 23, 2006
Pharmacokinetic evaluation of darbepoetin alfa for the treatment of pediatric patients with chemotherapy-induced anemiaJeffrey Blumer, Stacey Berg, Peter C Adamson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Pharmacokinetics of O(6)-benzylguanine in pediatric patients with central nervous system tumors: a pediatric oncology group studyKathleen Neville, Susan Blaney, Mark Bernstein, et al.
Journal of Public Health (Oxford, England)|February 21, 2018
One-on-one care management and procurement of Naloxone for ambulatory useRichard Whittington, Kathleen Whittington, John Whittington, et al.
Molecular Cancer Therapeutics|September 21, 2006
MDM2 inhibition sensitizes neuroblastoma to chemotherapy-induced apoptotic cell deathEveline Barbieri, Parth Mehta, Zaowen Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2005
Decision making in pediatric oncology: who should take the lead? The decisional priority in pediatric oncology modelSimon N Whitney, Angela M Ethier, Ernest Frugé, et al.
Pediatric Blood & Cancer|May 17, 2017
Dosing anticancer drugs in infants: Current approach and recommendations from the Children's Oncology Group's Chemotherapy Standardization Task ForceFrank M Balis, Richard B Womer, Stacey Berg, et al.
Journal of Pediatric Hematology/Oncology|May 7, 2002
Influence of phenytoin on the disposition of irinotecan: a case reportDaryl J Murry, Irene Cherrick, Veronia Salama, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Pediatric Blood & Cancer|November 19, 2016
Using decision modeling to guide drug allocation during a shortageHeidi V Russell, M Brooke Bernhardt, Stacey Berg
Pediatric Blood & Cancer|June 19, 2008
Valacyclovir and acyclovir pharmacokinetics in immunocompromised childrenLisa Bomgaars, Patrick Thompson, Stacey Berg, et al.
Cancer Chemotherapy and Pharmacology|October 11, 2003
Plasma and cerebrospinal fluid pharmacokinetics of SU5416 after intravenous administration in nonhuman primatesJamie Renbarger, Alexander Aleksic, Leticia McGuffey, et al.
Pediatric Blood & Cancer|November 23, 2006
Pharmacokinetic evaluation of darbepoetin alfa for the treatment of pediatric patients with chemotherapy-induced anemiaJeffrey Blumer, Stacey Berg, Peter C Adamson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Pharmacokinetics of O(6)-benzylguanine in pediatric patients with central nervous system tumors: a pediatric oncology group studyKathleen Neville, Susan Blaney, Mark Bernstein, et al.
Journal of Public Health (Oxford, England)|February 21, 2018
One-on-one care management and procurement of Naloxone for ambulatory useRichard Whittington, Kathleen Whittington, John Whittington, et al.
Molecular Cancer Therapeutics|September 21, 2006
MDM2 inhibition sensitizes neuroblastoma to chemotherapy-induced apoptotic cell deathEveline Barbieri, Parth Mehta, Zaowen Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2005
Decision making in pediatric oncology: who should take the lead? The decisional priority in pediatric oncology modelSimon N Whitney, Angela M Ethier, Ernest Frugé, et al.
Pediatric Blood & Cancer|May 17, 2017
Dosing anticancer drugs in infants: Current approach and recommendations from the Children's Oncology Group's Chemotherapy Standardization Task ForceFrank M Balis, Richard B Womer, Stacey Berg, et al.
Journal of Pediatric Hematology/Oncology|May 7, 2002
Influence of phenytoin on the disposition of irinotecan: a case reportDaryl J Murry, Irene Cherrick, Veronia Salama, et al.
Pageof 2